#Regulatory news
Explore tagged Tumblr posts
Text
Bitcoin and Altcoins Update: Market Movements and Key Developments
The cryptocurrency market has experienced some intriguing shifts recently, with Bitcoin and various altcoins demonstrating varying levels of performance. Here’s a detailed overview of the latest market movements and notable developments.
Bitcoin: A Modest Decline with Strong Weekly Gains
Bitcoin, the leading cryptocurrency, has seen a slight decline of 0.9%, bringing its current price to $64,166.3. Despite this recent dip, Bitcoin has shown significant strength over the past week, trading up by 8.5%. This positive weekly performance highlights Bitcoin's resilience and continued appeal as an investment asset, even amidst short-term fluctuations.
Ether: A Small Drop Amid Anticipated ETF Approval
Ether has fallen by 0.2%, settling at $3,444.58. The drop comes as market participants await potential regulatory news. Recent reports suggest that the Securities and Exchange Commission (SEC) might approve a spot Ether ETF as early as next week. Such approval could have substantial implications for Ether's market dynamics, potentially driving up its value as institutional investment opportunities become more accessible.
SOL: Noteworthy Surge with ETF News
In contrast to Ether’s slight decline, Solana (SOL) has surged by 3.8%. This increase follows reports indicating that a spot SOL ETF is also in the pipeline. The anticipated approval of such an ETF could enhance Solana's visibility and attract new investment, contributing to its recent upward momentum.
ADA and XRP: Downturns Amid Market Volatility
Both Cardano (ADA) and Ripple (XRP) have experienced notable declines. ADA fell by 2.3%, while XRP saw a more substantial drop of 4.7%. These downturns reflect broader market volatility and may be influenced by various factors, including regulatory uncertainties and shifting investor sentiments.
Meme Tokens: DOGE and SHIB Face Declines
Among meme tokens, Dogecoin (DOGE) and Shiba Inu (SHIB) have also faced declines. DOGE fell by 1.1%, while SHIB saw a more significant slide of 6.2%. The fluctuations in these tokens underscore the volatility often seen in the meme coin sector, where price movements can be heavily influenced by social media trends and speculative trading.
Conclusion
The cryptocurrency market continues to demonstrate its dynamic nature, with Bitcoin maintaining a strong weekly performance despite recent declines. Ether’s minor drop is tempered by the potential approval of a spot ETF, which could bolster its market position. Meanwhile, Solana’s recent rise reflects optimism around its forthcoming ETF, while ADA and XRP, along with meme tokens like DOGE and SHIB, face varying degrees of market pressure. As always, staying informed about these developments is crucial for investors navigating the ever-evolving crypto landscape.
#Cryptocurrency market#Bitcoin performance#Ether ETF approval#Solana surge#Cardano decline#Ripple market volatility#Meme tokens#Dogecoin decline#Shiba Inu price drop#Crypto market trends#Investment opportunities#Regulatory news#Market analysis#Crypto market shifts#Institutional investment in crypto#SEC crypto regulations#Crypto market dynamics#Crypto investment strategies#Altcoin performance#Cryptocurrency news
0 notes
Text
#medical device#import license medical devices#Class C & D medical device import license#medical device regulation#operon strategist#what is the right time to apply for import license for Class C & D medical device in india#class C & D medical device import in india#new timeline for class c & d medical device in india#Class C & D medical devices#update for medical device import#CDSCO guidlines#trending news for medical devices#trending news#CDSCO News#regulatory news
1 note
·
View note
Text
Considering everything going on with the missing submersible full of rich people who wanted to visit the titanic for 250,000 dollars a pop, I thought it would be a good time to link this Sunday morning segment that talks about the company and the submersible:
youtube
Namely, 2:40-4:00 where they specifically state how it's not approved by any regulatory authority in the liability agreement and it's operated via an Xbox controller or something among the many other erm, interesting design choices (like ceiling handles from camping world)
So you know, do with this info what you will
#personally I would not get in a small tube whose design is not certified by any relevant regulatory authority for a lot of money#I'd say it's akin to paying a million dollars to the monopoly man to get to the top of mount everest via large catapult#titanic#titanic submarine#submarine#tumblr news#submersible#Youtube
600 notes
·
View notes
Text
This is an important article by Linda Greenhouse, writing in The New York Times. Therefore, the link above is a gift 🎁 link, so anyone can read the article, even if they don't subscribe to the Times.
Below are some excerpts from the article:
To understand today’s Supreme Court, to see it whole, demands a longer timeline. To show why, I offer a thought experiment. Suppose a modern Rip Van Winkle went to sleep in September 2005 and didn’t wake up until last week. Such a person would awaken in a profoundly different constitutional world, a world transformed, term by term and case by case, at the Supreme Court’s hand. To appreciate that transformation’s full dimension, consider the robust conservative wish list that greeted the new chief justice 18 years ago: Overturn Roe v. Wade. Reinterpret the Second Amendment to make private gun ownership a constitutional right. Eliminate race-based affirmative action in university admissions. Elevate the place of religion across the legal landscape. Curb the regulatory power of federal agencies. [...} That was how the world looked on Sept. 29, 2005, when Chief Justice Roberts took the oath of office, less than a month after the death of his mentor, Chief Justice Rehnquist. And this year? By the time the sun set on June 30, the term’s final day, every goal on the conservative wish list had been achieved. All of it. To miss that remarkable fact is to miss the story of the Roberts court. It’s worth reviewing how the court accomplished each of the goals. It deployed a variety of tools and strategies. Precedents that stood in the way were either repudiated outright, as the Dobbs v. Jackson Women’s Health Organization decision did last year to Roe v. Wade and Planned Parenthood v. Casey, or were simply rendered irrelevant — abandoned, in the odd euphemism the court has taken to using. In its affirmative action decision declaring race-conscious university admissions to be unconstitutional, Chief Justice Roberts’s majority opinion did not overturn the 2003 Grutter decision explicitly. But Justice Thomas was certainly correct in his concurring opinion when he wrote that it was “clear that Grutter is, for all intents and purposes, overruled.” Likewise, the court has not formally overruled its Chevron decision. Its administrative-law decisions have just stopped citing that 1984 precedent as authority. The justices have simply replaced Chevron’s rule of judicial deference with its polar opposite, a new rule that goes by the name of the major questions doctrine. Under this doctrine, the court will uphold an agency’s regulatory action on a major question only if Congress’s grant of authority to the agency on the particular issue was explicit. Deference, in other words, is now the exception, no longer the rule. But how to tell a major question from an ordinary one? No surprise there: The court itself will decide. [...] My focus here on what these past 18 years have achieved has been on the court itself. But of course, the Supreme Court doesn’t stand alone. Powerful social and political movements swirl around it, carefully cultivating cases and serving them up to justices who themselves were propelled to their positions of great power by those movements. The Supreme Court now is this country’s ultimate political prize. That may not be apparent on a day-to-day or even a term-by-term basis. But from the perspective of 18 years, that conclusion is as unavoidable as it is frightening.
#us supreme court#18 years of the roberts' court#chief justice john roberts#affirmative action#second amendment#separation of church and state#regulatory agencies#women's reproductive health#linda greenhouse#the new york times#gift link
134 notes
·
View notes
Text
I say this as a c2 drug patient myself but. I don’t like you c2 prescription people you guys are rather rude
#riv rambles#listen they give me a set of regulatory protocols to follow#I just follow them#why tf are you mad at me#get mad at your doctor or insurance or manufacturer#I cannot help that insurance has limits to how much they cover#or that your doctor didn’t send in the prescription#or that it’s on backorder#I am just doing what the screen tells me can you please stop taking out your anger on the wrong person#the pharmacy cannot help you get a new prescription or order something faster or get ur insurance to cover something okay#like ykw I think your dosage needs to be lowered actually#you are clearly a little too dependent on this if one day without it will make you this agitated and unpleasant#Jesus fucking hell
2 notes
·
View notes
Text
Why Accurate Financial Statements Matter for Your Business
Accurate financial statements are the backbone of any successful business, providing insights into your company’s financial health and guiding decision-making. At SAI CPA Services, we offer expert financial statement preparation, ensuring your records are precise and reliable.
Why Accurate Financial Statements Matter
Accurate financial statements allow businesses to plan for the future, meet regulatory requirements, and demonstrate financial stability. Here’s how our services benefit your business:
Informed Decision-Making: Our financial statement services give you a clear understanding of your revenue, expenses, and overall financial position, enabling you to make informed business decisions.
Investor Confidence: Lenders and investors rely on accurate financial statements to evaluate your business’s health. A professionally prepared statement adds credibility and trust.
Regulatory Compliance: We ensure that your financial statements comply with all necessary accounting standards and regulations, avoiding penalties and ensuring transparency in your operations.
How SAI CPA Services Can Help
At SAI CPA Services, we provide accurate and detailed financial statements to help your business stay on track. Our team ensures that your financial records are up-to-date, reliable, and compliant.
Connect Us: https://www.saicpaservices.com https://www.facebook.com/AjayKCPA https://www.instagram.com/sai_cpa_services/ https://twitter.com/SaiCPA https://www.linkedin.com/in/saicpaservices/ https://whatsapp.com/channel/0029Va9qWRI60eBg1dRfEa1I
908-380-6876
1 Auer Ct, 2nd Floor
East Brunswick, NJ 08816
#SAICPAServices#financial statements#business growth#financial services#accounting#accounting services#cpa#new jeresy#investor confidence#regulatory compliance services
2 notes
·
View notes
Text
Having a normal one about the events of the Conscience of the King.
Written to go alongside the fic "Regulatory Relations"
Lyrics below the cut!
Nightmares - everybody's got one, and this one is mine
I put the devil in my crosshairs and the bullet went wide
I took my shot but he got away
I know he'll hunt me down someday
I missed my shot at the devil and there's nowhere to hide
He knows my name and he haunts my steps
He'll wear me down till there's nothing left
My soul and my sins and the devil make three
And he's coming, he's coming for me
He's in my dreams and he knows my heart
I feel him reaching from the dark
I got away, but I'll never be free
If he's coming, he's coming for me
And he's coming, he's coming for me
Hell is a pretty little place with nothing to eat
And the devil takes you by the hand and promises meat
He'll chew you up and he'll spit you out
He lifts you up till he lets you drown
You can call his bluff but the house can't be beat
He knows my name and he haunts my steps
He'll wear me down till there's nothing left
My soul and my sins and the devil make three
And he's coming, he's coming for me
He's in my dreams and he knows my heart
I feel him reaching from the dark
I got away, but I'll never be free
If he's coming, he's coming for me
And he's coming, he's coming for me
All I know is this
If you aim at the devil, you'd better not miss
All I know is this
If you aim at the devil, you'd better not miss
If you aim at the devil, you'd better not miss
If you aim at the devil, you'd better not miss
#southern gothic#star trek filk#filk#the conscience of the king#regulatory relations#original music#new music#americana music#SoundCloud
8 notes
·
View notes
Text
zooms in on myself in my job, two years down the line. isn't it spooky i can have whole technical conversations now and make strategic decisions because i actually understand the work now?
#realizations i make after my team meeting where im like whoa. im a fully blown useful knowledgeable person now#they arent really carrying me anymore! im just doing it and saying stuff and being confident about it!#also yeah it takes like 2 years to understand this job LOL#the entire structure and the way the org works and the complex regulatory dynamics between fed/state/tribe/city#it's not something you grasp from the outside in. but if i were to switch to another job it would be simpler now#but starting as a brand new fresh out of college employee it takes TIME to even figure out where the limits of our oversight is
16 notes
·
View notes
Text
Radical thoughts: in Western societies it is constantly re-debated whether terminating a pregnancy should be illegal, while it is never debated if for example abandoning a partner during pregnacy should be illegal, indicates that the governing structures and politics are still infused with deep sexism. This one-sidedness reveals the debate is really about the right to control women's bodies (and people traditionally deemed women), and not about protecting new life.
#feminism#sexism#abortion rights#politics#i want to clarify i am not taking a side on whether the alternative i mention would be good or not#i am pointing out that the concept of regulatory interference in the traditionally male role in the start of new life is almost non-existent#which indicates a patriachal hang-over in the whole framing of this issue
15 notes
·
View notes
Text
National Press Day is observed on November 16, every year, in India to celebrate the importance of a free and responsible press in a democratic society. The day is celebrated to commemorate the establishment of the Press Council of India, which acts as a regulatory body for the news media in the country. #NationalPressDay build your brand with digital media and benefit from social media branding contact Media Heights. By Mediaheightspr.com #Inboundmarketing #MEDIAHEIGHTS #digitalmarketingcompany #searchengineoptimization #content #instagrammarketing #worldcancerday #advertisingagency #web #MEDIAHEIGHTSPRCOM #best #public #relation #agency #in #chandigarh #mohali #punjab #north #india #buildingrelationships #globally #customer #internetbanding — at media heights #smo #branding #facebook #twitter #marketingonline #brand #searchengineoptimization #internetmarketing #follow #digitalagency #marketingagency #motivation #digitalmarketingtips #onlinebusiness #websitedesign #marketingonline #brand #searchengineoptimization #content #instagrammarketing #advertisingagency #web #technology #onlinebranding #branding360degree #SEO #SEObrandingagency #websiteranking #websitetrafic #Digitalmarketing #mediaheights #OnlineAdvertising #instagrammarketing #advertisingagency #web #marketingonline #brand
#National Press Day is observed on November 16#every year#in India to celebrate the importance of a free and responsible press in a democratic society. The day is celebrated to commemorate the esta#which acts as a regulatory body for the news media in the country.#NationalPressDay build your brand with digital media and benefit from social media branding contact Media Heights. By Mediaheightspr.com#Inboundmarketing#MEDIAHEIGHTS#digitalmarketingcompany#searchengineoptimization#content#instagrammarketing#worldcancerday#advertisingagency#web#MEDIAHEIGHTSPRCOM#best#public#relation#agency#in#chandigarh#mohali#punjab#north#india#buildingrelationships#globally#customer#internetbanding — at media heights#smo
3 notes
·
View notes
Text
cw ai, suicidal ideation, negativity of all things to not regulate. why AI
#just saw some jpn AI regulatory news being shared in some of the ethical AI servers im in and like#“nah copyright just doesnt apply actually. lol have fun” okay ill kms then!#jpn already has an issue with creatives and workers overworking. this will only make the issue worse!#theres nothing people can do about having their entire identities stolen? ok#negative#ai bs#cw suicidal ideation#like what will there be left to live for lol#cant even create as a hobby because corps will feed anything I share digitally into a machine without my permission!#secret zine club where we physically meet and read each others works (you cant take home a copy)#its viscerally like. evil to me. to just steal someones voice and edit it freely. lol which is what this is about in this case#thats. one of the closest things to being part of their soul. what are you ursula?#why are we in the Bad timeline dude. i hope like hell this somehow comes out in the wash#like this is all some big overreaction on our parts and itll become normal and it isnt as bad as we think#but... idk
4 notes
·
View notes
Text
I was writing this in the tags but I want to include sources. I’m gonna tell you why drugs don’t go generic right away, and I want you to know that I don’t agree with the reasoning here, but this is how the system works.
New drugs are priced so much to recoup some of the losses of research. Drug research is insanely expensive. Whether you’re talking about buffers and reagents in the lab, machines designed to give scientists highly specific information, or required animal research, it’s EXPENSIVE. I tried to pull up an example for a standard microscope but companies that make lab equipment don’t have prices on their website, you have to fill out a form to request a quote.
So, lab equipment is expensive. You also have to go through rounds of animal testing. One lab mouse can cost hundreds of dollars, depending on how it has been genetically designed to give the best research results. And spoiler alert, you need repeat results, meaning multiple mice, and then larger lab animals because humans aren’t mice and we need to be sure drugs are safe before testing them on humans. Raising and caring for lab animals also takes lots of highly trained staff, which adds to the expense. This is partially why a lot of scientists in animal research are pushing for alternative research methods, because it is more humane and more cost effective to reduce our reliance on animal models.
So it’s expensive to do research, and then you get into patent law. Drugs get 20 years of patents, although that’s from when the patent was filed - which is often BEFORE the drug hits the market. You can patent a drug and then still have several more years of development. So in practice, drugs are often on the market for less than their patent time. From the drug company’s perspective, they need to recoup their losses in that amount of time, and the high price of the name brand drug is funding the ongoing research of the next drug.
Generic drugs don’t have to go through animal or clinical trials, so companies making generic drugs ONLY have to consider the manufacturing cost when pricing their drugs. This is why they’re so much cheaper, because all they have to prove is that their drug is the same as the patented one.
Lenacapavir is STILL IN CLINICAL TRIALS, according to the source linked above. It hasn’t been approved for prevention. I believe it will probably be approved, but the point is that it’s a very new drug and still within its patent range. I’m not entirely sure when the patent was filed, but the fact is that it will have a generic eventually. Just not right now. But the reasoning for drugs being so expensive is that they’re factoring in the cost of research, not just the cost of production. I don’t like it! It’s a bad system! But that’s why it is the way it is
Source
#I am having trouble finding sources but there’s more complications as well#bc the companies can use their research that they did in the US to support approval in other countries#there are places that just do a lit review and approve drugs if the FDA approved them#but then mandate lower costs#which means that US consumers end up paying more to support the lower prices of other countries#bc we have less regulatory protection#and you have to factor in the way insurance inflates costs bc you have to go through them#I doooont remember which book I read this in though so please question my summary in these tags#like continue being angry at pharma companies because there’s no reason for things like insulin to be expensive#but every once in a while I see things like this where people are like new miracle drug but no generic!!! evil!!!#and I’m like THATS HOW PATENT LAW WORKS#YOU DONT GET TO HAVE A GENERIC WHILE THERE IS AN ACTIVE PATENT#like the real solution would be to abolish capitalism but until we get there#you have to pay the salaries of people who breed mice and manufacture microscopes and maintain microscopes for the scientists to use them#and all of that builds up to expensive drug prices#now if the company would reinvest ALL of that profit into new research I’d be much more okay with higher prices#it’s a taxing the rich problem more than it is a generic vs patent problem
37K notes
·
View notes
Text
Looking for the right clinical study design firm in North Carolina? Discover key factors to consider when selecting an expert team for your clinical trials. From protocol development to data analysis, ensure your research is in capable hands with experienced professionals in North Carolina. Learn how to make the best choice for successful study outcomes.
#clinical pharmacology boston-cambridge#pharmacometrics new jersey - princeton#regulatory strategy boston-cambridge#fda new york - new york city#modeling and simulation m&s north carolina#clinical study protocol san diego#clinical study report san diego#research triangle park
0 notes
Text
dahabminers.com
#Bitcoin Mining#Cryptocurrency Mining#Blockchain Technology#Mining Hardware#ASIC Miners#GPU Mining#Mining Profitability#Renewable Energy for Mining#Crypto Economics#Decentralization#Mining Pools#Hashrate#Mining Algorithms#Proof of Work (PoW)#Bitcoin Economics#Crypto Market Trends#Mining Challenges#Green Energy Solutions#Mining Security#Crypto Regulatory News
0 notes
Text
Regulatory filing: Changan files for battery swap-enabled electric sedan
The Changan Oshan 520’s support for battery swap has sparked some speculation that the electric sedan could come from the Nio battery swap alliance, but that seems unlikely. Chinese auto giant Changan Automobile (SHE: 000625) has filed for a battery-swap-enabled electric sedan that may not come from the Nio-led (NYSE: NIO) battery swap alliance, despite their partnership. China’s Ministry of…
0 notes
Text
New Jersey Governor Murphy signs law that will pull Delta-8, THC seltzers from shelves
In one fell swoop, the loophole that allowed intoxicating hemp products — from candy-shaped edibles and cannabis flower available at gas stations to the THC seltzers on liquor store shelves — has been closed off. Gov. Phil Murphy on Thursday signed into law a bill establishing regulations for intoxicating hemp products, placing their manufacturers and retailers under the purview of the New Jersey…
0 notes